Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bunn

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Treatment Reports|April 1, 1979
Cytogenetic abnormalities in patients with cutaneous T-cell lymphomasJ Whang-Peng, P Bunn, T Knutsen, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Combined modality therapy in small cell lung cancerP Bunn, R Arriagada, N Choi, et al.
The Journal of Experimental Medicine|May 1, 1985
Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancerA Doyle, W J Martin, K Funa, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1997
5th I.A.S.L.C. Lung Tumor Biology Workshop, August 13-17, 1996, Ermatingen, SwitzerlandP Bunn, D Carbone, J Grim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Fifth I.A.S.L.C. Lung Tumor Biology Workshop, August 13-17, 1996, Ermatingen, SwitzerlandP Bunn, D Carbone, J Grim, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2000
Altered HOX and WNT7A expression in human lung cancerR Calvo, J West, W Franklin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2019
HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinibY Wang, T Jiang, Z Qin, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Treatment Reports|April 1, 1979
Cytogenetic abnormalities in patients with cutaneous T-cell lymphomasJ Whang-Peng, P Bunn, T Knutsen, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Combined modality therapy in small cell lung cancerP Bunn, R Arriagada, N Choi, et al.
The Journal of Experimental Medicine|May 1, 1985
Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancerA Doyle, W J Martin, K Funa, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1997
5th I.A.S.L.C. Lung Tumor Biology Workshop, August 13-17, 1996, Ermatingen, SwitzerlandP Bunn, D Carbone, J Grim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Fifth I.A.S.L.C. Lung Tumor Biology Workshop, August 13-17, 1996, Ermatingen, SwitzerlandP Bunn, D Carbone, J Grim, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2000
Altered HOX and WNT7A expression in human lung cancerR Calvo, J West, W Franklin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2019
HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinibY Wang, T Jiang, Z Qin, et al.
Pageof 2